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Abstract. Particle size is a critical parameter for controlling pharmaceutical quality. The aim of this study
was to assess the size of the micrometer-scale active pharmaceutical ingredients (API) in tablets using
Raman chemical imaging and to understand the effects of formulation on particle size. Model tablets
containing National Institute of Standards and Technology traceable polystyrene microsphere size stan-
dards were developed to determine the binarization threshold value of Raman chemical images for API
particle sizing in specific formulations and processes. Three sets of model tablets containing 5, 10, and
15 μm polystyrene microspheres, used to mimic API, were prepared using a commercial tablet formula-
tion (Ebastel tablets, mean API particle size was about 5 μm). Raman mapping with a 50× objective (NA,
0.75) was applied to tablet cross-sections, and particle size of polystyrene microspheres was estimated
from binary images using several binarization thresholds. Mean particle size for three sets of polystyrene
microspheres showed good agreement between pre- and postformulation (the slope=1.024, R=1.000) at
the specific threshold value ((mean+0.5σ) of the polystyrene-specific peak intensity histogram), regard-
less of particle agglomeration, tablet surface roughness, and laser penetration depth. The binarization
threshold value showed good applicability to Ebastel tablets, where the API-specific peak intensity
histogram showed a pattern similar to that of polystyrene microspheres in model tablets. The model
tablets enabled determination of an appropriate binarization threshold for assessing the mean particle size
of micrometer-scale API in tablets by utilizing the unique physicochemical properties of polystyrene
microspheres.
KEY WORDS: binarization threshold; image analysis; particle size; polystyrene microspheres; Raman
chemical imaging.
INTRODUCTION
The efficacy of pharmaceutical tablets depends on both
the physical and chemical properties of the active pharmaceu-
tical ingredient (API). Particle size, shape, and solid-state
form of the API and its spatial distribution in the excipient
matrix control the dissolution rate, bioavailability, and stabil-
ity of the final product (1–5).
In pharmaceutical production, the size of ingredient par-
ticles is a critical process parameter for ensuring product
quality. This size is determined by techniques such as micros-
copy and image analysis (4–9), sieving (5,9), laser diffraction
(4–6,8–11), dynamic light scattering (4,5,7,12), electrical zone
sensing (coulter counter) (4,5,8,10), time-of-flight measure-
ments (4,6,11), and cascade impaction (4,13). The API is often
micronized prior to or during the formulation process, and its
size is tightly controlled. However, API size after
micronization does not always reflect its size in a complex
dosage matrix. The API particles undergo physical stresses
during formulation processes such as mixing, granulation, dry-
ing, blending, tableting, and coating, and even during storage
of the final product, depending on its formulation and pack-
aging. However, API particle size in multiple components
cannot be specifically assessed using the aforementioned de-
vices. Thus, determination of API particle size in the excipient
matrix of the final product is a major challenge in pharmaceu-
tical development.
Recently, vibrational spectroscopy (infrared (IR), near-
infrared (NIR), and Raman) has been widely used as a pow-
erful tool in pharmaceutical production to analyze pharma-
ceutical products and to monitor pharmaceutical processes
(14–20). Vibrational spectroscopy requires little or no sample
preparation; can be used to characterize functional groups;
and is fast, nondestructive, accurate, and economical. Vibra-
tional spectroscopic imaging is also used in chemical imaging
(CI) for pharmaceutical production. Using this technique,
imaging and vibrational spectroscopy are integrated to obtain
both spatial and spectral information on pharmaceutical
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products (21–28). The high selectivity of vibrational spectros-
copy for functional groups means that the concentration and
distribution of ingredients can be examined. Thus, even
though pharmaceutical formulations and their processes in-
volve multiple component systems, API particle size and its
distribution (uniformity) in the excipient matrix are specifical-
ly assessed using spectroscopy and chemical imaging
(14,25,27,28).
Several studies have reported the application of Raman
chemical imaging (Raman CI) for assessing API particle size
in pharmaceutical formulations (25,30,31). A number of well-
resolved fundamental intra- and intermolecular stretching and
bending modes are typically observed in API Raman spectra.
Raman CI is suitable for establishing the chemical identity of
API particles that have a specific Raman peak. Several factors
contribute to the superiority of Raman CI for characterizing
APIs in the excipient matrices of tablets (29,30). Henson and
Zhang reported characterizing drugs in low-dosage pharma-
ceutical tablets using a Raman line mapping instrument (30).
Particle size and spatial distribution of low dosage (0.5 wt.%)
APIs in the tablet matrix were estimated using API binary
images from Raman maps. The estimated API particle size
was dependent on the particle size distribution of the ingoing
API material. Doub et al. used wide-field Raman CI to assess
the API-specific particle size in nasal spray formulations (31).
A Raman imaging particle size distribution protocol was de-
veloped and validated by using polystyrene microsphere size
standards. Good statistical agreement was obtained between
the reported and estimated sizes of the polystyrene particles
by Raman CI. However, few studies have rigorously estimated
the binarization threshold values for image analysis of phar-
maceutical formulations; the values reported have arbitrarily
influenced quantitative particle sizing in multiple component
systems (26,30,31).
In this study, we investigated the use of Raman CI for
sizing micrometer-scale API particles in a pharmaceutical tab-
let in order to better understand the effects of formulation on
API particle size. Model tablets were developed in order to
establish an appropriate binarization threshold value for im-
age analysis of multiple component systems. Polystyrene mi-
crosphere size standards were used as targets for API particle
sizing in the model tablets. These tablets had the same excip-
ient matrix as commercial tablets (Ebastel tablets). Polysty-
rene particle size standards (hereinafter, PS microspheres) are
designed for calibrating particle size analyzers and are trace-
able to the U.S. National Institute of Standards and Technol-
ogy (NIST). Here, the NIST traceable PS microspheres acted
as internal size standards in the model tablets for Raman
particle sizing. Application of Raman CI to the model tablets
provided a quantitative basis of the threshold value for
assessing the mean particle size of the API in the Ebastel
tablets.
MATERIALS AND METHODS
Materials and Tablet Preparation
Ebastel, a widely used antihistamine, was selected as the
model drug formulation. Ebastel tablets were prepared ac-
cording to a commercial process. The API of Ebastel tablets,
ebastine (6.25 wt.%), was micronized prior to tablet
formulation. Commercial ebastine (Dainippon Sumitomo
Pharma, Osaka, Japan) was used to obtain the Raman signa-
ture of the pure ingredient (Fig. 1). Pure excipients were also
examined to obtain their Raman signatures. The inactive in-
gredients were lactose (DMV-Fonterra Excipients, Goch,
Germany), carmellose calcium (Nichirin Chemicals, Hyogo,
Japan), crystalline cellulose (Asahi Kasei Chemicals, Tokyo,
Japan), hydroxypropyl cellulose (Nippon Soda, Tokyo, Ja-
pan), magnesium stearate (Taihei Chemicals, Osaka, Japan),
and light anhydrous silicic acid (Nippon Aerosil, Tokyo, Ja-
pan). Three sizes of NIST traceable PS microspheres with
mean particle diameters of 5, 10, and 15 μm (Duke Scientific,
Palo Alto, CA, USA) were used in the model tablets. The
certificate stated that the precise mean particle diameters of
the polystyrene particles were 4.9±0.4, 9.8±0.5, and 15.8±
0.6 μm as measured by optical microscopy. Three types of
model tablets were prepared according to the Ebastel tablet
formulation process, using the polystyrene particles instead of
ebastine.
Preparation of Tablet Cross-sections
Tablet cross-sections were prepared for scanning electron
microscopy (SEM), 3D confocal laser microscopy, and Raman
microscopy. Each tablet was secured in an epoxy resin solu-
tion, and the resin was then cured. The tablet was microtomed
(Ultracut UCT, Leica, Wetzlar, Germany) to expose its inte-
rior and produce a smooth, flat surface.
Instrumentation
SEM images were acquired under high vacuum on a
scanning electron microscope (SU1510, Hitachi High-Tech,
Tokyo, Japan). The accelerating voltage was 5.00 kV, and
the working distance was 15.0 mm. The sample was sputter
coated with Au/Pd using a vacuum evaporator.
The 3D tablet surface was visualized with a 3D measuring
laser microscope (LEXT OLS4000, Shimadzu, Kyoto, Japan).
Image processing was performed using LEXT software
(Shimadzu). Image size was 130×130 μm with 1,024×1,024
pixels. The diameter of the laser spot was approximately
0.4 μm, using a 100× objective and a numerical aperture
(NA) of 0.95. The laser input was 1 mW, and the wavelength
was 405 nm. After data collection, images were leveled to
remove the slope caused by tilting of the tablet surface.
Raman spectra were collected using a Raman microscope
(LabRAM; ARAMIS, Horiba, Kyoto, Japan) and LabSpec 5
Software (Horiba, Kyoto, Japan). Raman scattering was
achieved by delivering He-Ne laser (633 nm) excitation of
up to 17 mW through a 50× objective with a NA of 0.75 to
generate a laser spot diameter of approximately 1 μm. An
edge filter was used for Rayleigh light rejection. A 300
grooves /mm dispers ive gra t ing combined wi th a
thermoelectrically cooled, silicon charge-coupled device de-
tector achieved a spectral resolution of approximately 4 cm−1.
The spectrometer was calibrated each day in reference to
the 520 cm−1 Raman band of a silicon wafer. After calibration,
grating was held in a fixed position throughout data collection.
A static Raman spectral window of 3,700–200 cm−1 was
used. A motorized XY stage allowed the samples to be
scanned with a 1-μm step size under the excitation beam in
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Fig. 1. Raman spectra of tablet components (left) and second derivatives of the spectra (right). a PS
microspheres, b ebastine, c lactose, d carmellose calcium, e crystalline cellulose, and f hydroxypro-
pyl cellulose
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order to build an array of spectra spanning a two-dimensional
area (pixels). The tablet spectrum acquisition time per pixel
was typically 0.5 s. Data acquisition covered an area of
10,000 μm2 (100×100 μm), which consisted of 10,000 spectra
with a total acquisition time of nearly 2 h. Three areas in the
cross-section of each tablet were examined in this study.
Particle size measurements were carried out on ebastine
prior to formulation. The ebastine particle size was measured
at a magnification of 50× in a dry powder dispersion
particle image analyzer (Morphologi G2; Malvern Instru-
ments, Malvern, UK). Powder was also analyzed using a
flow particle image analyzer (FPIA-3000S; Malvern Instru-
ments) with 0.1% neutral surfactant in water as a
suspending agent after 30 s sonication. Suspensions were
stirred at 300 rpm. Ebastine particle size was measured at
a magnification of ×10.
Fig. 2. SEM micrographs of PS microspheres and ebastine. a 5 μm, b 10 μm, and c 15 μm PS
microspheres, and d ebastine. Scale bar 20 μm
Fig. 3. SEMmicrographs of tablet cross-sections. Tablet containing a 5 μm, b 10 μm, and c 15 μm PS
microspheres, and d ebastine (Ebastel tablet). Scale bar 20 μm
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Raman Particle Sizing
Raman spectral data were analyzed using ISys 4.0 CI
software (Malvern Instruments). The Raman particle sizing
procedure after data acquisition consisted of the following
steps: (1) data preprocessing, (2) data analysis and feeding
the results back into the Raman chemical images, (3) creating
binary images at the threshold value, and (4) particle size
analysis.
Spectra for each pixel were subjected to second-deriva-
tive preprocessing (Savitzky-Golay, 31-point width) to remove
baseline fluctuations and to improve the image contrast and
fidelity, and data analysis was then performed by univariate
analysis using a specific Raman peak intensity at one particu-
lar wavenumber channel. Many API molecules show specific
Raman peaks, which allow them to be distinguished from
excipients. By this means, Raman chemical images were
produced.
Figure 1a–f displays Raman spectra and the correspond-
ing second derivatives for PS microspheres, ebastine, lactose,
carmellose calcium, crystalline cellulose, and hydroxypropyl
cellulose. The peak at 1,605 cm−1 in the second-derivative
spectrum provided the best discrimination between the PS
microspheres and the excipients. For ebastine, the peak at
1,601 cm−1 was specific and the peak at 1,601 cm−1 achieved
similar intensity as the PS microsphere peak at 1,605 cm−1, at
unit exposure time. In this study, Raman chemical images
were acquired using the specific peaks at 1,605 cm−1 for PS
microspheres and 1,601 cm−1 for ebastine. These peaks were
also used for binary imaging with binarization thresholds.
For particle size analysis, each particle was approximated
to a circle that occupied the same area as the particle. The
Fig. 4. 3D profiles of tablet cross-sections. Cross-sections for a model tablet (PS micro-
spheres) and b Ebastel tablet
379Model Tablets for Raman Particle Sizing
particle size calculated from the pixels was based on the mean
equivalent particle diameter, represented by the mean diam-
eter of its corresponding approximated circle.
Binarization Threshold
Binarization is a critical step for image analysis as the
generated binary image with the binarization threshold value
influences particle sizing results. In binarization, pixels with a
peak intensity at or above the threshold value were set to 1
and were considered as the object, whereas pixels with a peak
intensity below the threshold value were set to 0 and were not
considered to be the object. Binary images are projected two-
dimensionally with clear separation between the object and
the background.
Spectroscopic discrimination was observed in this study,
as mentioned above; both PS microspheres and ebastine pro-
vided a negative peak in the second derivatives, whereas other
ingredients showed no peaks. These provided an opportunity
to develop a binary image based on observing only the pixels
with a negative second-derivative intensity, and this technique
is one of the useful approaches (28). In the present study, an
objective lens with a high magnification was used, and the
binary threshold value controls particles caused by three-di-
mensional effects (roughness of formulation and laser pene-
tration). In addition, the threshold controls pixels rich in
excipients, and is not suitable for being recognized as the
object. Thus, the binary threshold value determines the parti-
cle agglomeration and segregation in multiple component
system for image analysis, and is not necessarily 0.
In this study, the second-derivative spectrum was multi-
plied by−1, and the threshold value was optimized as the mean
plus one half the standard deviation (mean+0.5σ) of the
specific peak intensity histogram in each area (pixels).
RESULTS
Characterization of Tablet Cross-sections
SEM and 3D confocal laser microscopy were used to
visualize tablet surface profiles. Figure 2a–d shows SEM mi-
crographs of 5, 10, and 15 μm PS microspheres and ebastine
particles prior to formulation, respectively. The majority of
ebastine particles in the SEM micrographs had a size distribu-
tion from 5 to 15 μm, although particles smaller than 5 μm
were also observed. Figure 3a–d shows the tablet cross-sec-
tions. Micrographs indicate that the shape and size of PS
microspheres in each model tablet remained unchanged. Fur-
thermore, there were no visual differences between the
ebastine particles and the excipients in SEM micrographs.
Shape and size of particles were not evaluated in micrographs.
The 3D profiles of representative cross-sections of the
model tablet and the Ebastel tablet were measured using a
3D measuring laser microscope (Fig. 4). This method is effi-
cient because quantitative roughness can be measured. The
3D profile images indicate that the peaks and valleys from the
averaged surface (yellow to green; Fig. 4) are within the range
of ±10 μm in both tablets. The profiles verify that the ×50
objective used for Raman mapping allowed adequate exami-
nation of the tablet surface in this formulation.
Application of Raman CI to Model Tablets
Raman CI was applied to each cross-section of the model
tablets. Figure 5 shows representative Raman chemical images
of the model tablet cross-section for 10 μm PS microspheres,
developed based on the peak intensity of each pixel at
1,605 cm−1. Figure 5a is a Raman chemical image
constructed using the raw Raman spectra, and Fig. 5b is the
same image after second-derivative preprocessing. Figure 6
shows the intensity histogram at 1,605 cm−1 of the Raman
chemical image after second-derivative preprocessing;
Fig. 7a–d shows the binary images derived from each
binarization threshold intensity in the intensity histograms:
the mean, the mean+0.5σ, the mean+1.0σ, and the mean+
1.5σ.
Binarization Threshold Value Determination
The appropriate binary threshold value was determined
in order to accurately assess the true mean particle size of the
PS microspheres in each model tablet containing individual PS
microspheres, agglomerated particles, and colocalized parti-
cles in the binary images.
Fig. 5. Raman chemical images of cross-section of model tablet
(10 μm PS microspheres). Raman chemical images at 1,605 cm−1 a
prior to preprocessing and b after preprocessing
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The threshold value of the mean+0.5σ was applied to
image analysis. The binary images of each model tablet
cross-section are shown in Fig. 8, and the particle sizing results
are summarized in Table I. The results for the PS micro-
spheres prior to formulation are also shown.
The recoveries (the mean particle size ratio of the post-/
preformulation samples, in percent) were 98% (range, 91–
112%) for the 5 μm PS microspheres, 96% (range, 93–
106%) for the 10 μm PS microspheres, and 101% (range,
90–107%) for the 15 μm PS microspheres.
Validation of Binarization Threshold Value
Validity of binarization threshold value was tested
further. Analyses were conducted at the other binarization
threshold values; the mean, the mean+1.0σ, and the
mean+1.5σ. The results were compared with those for
the binarization threshold value of the mean+0.5σ
(Table II). The higher the threshold value was set, the
smaller the mean particle size and the recovery in each
tablet became. For the threshold value of the mean, the
recoveries for the 5 and 10 μm PS microspheres were
similar to those of the mean+0.5σ; however, the recovery
for the 15 μm microspheres was apparently higher than
that for the mean+0.5σ. The correlation for the mean
particle size of the PS microspheres of the pre- and
postformulation at each threshold value is shown in
Fig. 9. The thresholds of the mean, the mean+1.0σ, and
the mean+1.5σ, produced a regression line with a slope of
1.13, 0.78, and 0.49, respectively, whereas at the threshold
value of the mean+0.5σ, the slope was 1.02.
Application of Binarization Threshold Value to Ebastel Tablet
Prior to formulation, the micronized ebastine mean par-
ticle size and its standard deviation were determined using
Raman CI, and were also estimated using other particle image
analyzers (Morphologi G2 and FPIA-3000S). The Raman
Fig. 7. Binary images of 10 μm PS microspheres in model tablet at each threshold value. Threshold
value of a mean, b mean+0.5σ, c mean+1.0σ, and d mean+1.5σ in the intensity histogram
Fig. 6. Intensity histogram at 1,605 cm−1 after preprocessing (10 μm
PS microspheres). Red and blue dashed lines indicate maximum and
threshold intensity, respectively
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chemical image of ebastine prior to formulation is shown in
Fig. 10. The results are summarized in Table III; there were no
significant differences in mean particle size determined by
various methods.
Raman CI was used to produce a chemical image of the
cross-section of an Ebastel tablet, based on the peak intensity
at 1,601 cm−1 after second-derivative preprocessing. The
resulting intensity histogram is shown in Fig. 11a. The
ebastine particles could be as clearly identified as the PS
microspheres in tablets using the Raman chemical image as
shown in Fig. 11b. The binary threshold value of the mean+
0.5σ was applied, and the resulting binary image is shown in
Fig. 11c.
Particle sizing for the three areas in the cross-section of
the Ebastel tablet is summarized in Table IV. The mean size
recovery (the mean particle size ratio of the post- and
Fig. 8. Binary images of pre- and postformulation PS microspheres; a 5 μm PS microspheres
(preformulation), b 5 μm PS microspheres (postformulation), c 10 μm PS microspheres
(preformulation), d 10 μm PS microspheres (postformulation), e 15 μm PS microspheres
(preformulation), and f 15 μm PS microspheres (postformulation)
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preformulation samples, in percent) was 105% (range, 96–
112%). The relative standard deviation of the particle size
was 92% for preformulation ebastine and 97% (range, 87–
110%) for postformulation ebastine. The original size of the
ebastine particles in the Ebastel tablets was retained during
the formulation process.
DISCUSSION
Application of Raman CI to Model Tablets
Comparison of Fig. 5a, b demonstrates that the PS micro-
spheres were clearly identified by second-derivative prepro-
cessing; for example, the red area in the top right corner of
Fig. 5a is a region of excipients and is caused by elevation of
the baseline, but is absent after preprocessing (Fig. 5b). In
Fig. 5b, polystyrene particles are generally seen in only the red
and yellow regions, and stable images are created. Therefore,
using the second derivative, stable Raman chemical images
not affected by the background spectrum can be obtained, and
discrimination between the object and the background was
enhanced. As shown in Fig. 6, the histogram depicts two
domains clearly, and the higher peak intensity region separat-
ed by the maximum intensity and the binary threshold inten-
sity can be taken to be the polystyrene in the tablets.
Binary images obtained using each binarization threshold
intensity indicated that there were areas of separated, individ-
ual PS microspheres, as well as areas of agglomerated and
colocalized PS microspheres due to particle agglomeration,
tablet surface roughness, and laser penetration depth
(Fig. 7). Each particle or area changed slightly for each binary
threshold value. Figure 7a shows extraction of the red and
Table I. Results for Pre- and Postformulation PS Microsphere Particle Sizing
Item







1 2 3 Mean 1 2 3 Mean 1 2 3 Mean
Mean (μm) 6.30 7.07 6.36 5.74 6.20 10.58 11.17 10.16 9.81 10.19 15.79 16.42 14.15 16.96 15.90
STD (μm) 0.58 4.73 4.37 3.53 4.05 0.65 5.70 5.35 5.97 5.59 0.36 10.13 8.12 4.13 6.80
Area (%) 3.46 11.18 14.97 17.39 14.51 6.18 9.63 14.41 19.40 14.48 7.84 10.89 12.03 19.01 13.98
Particle
number
11 20 32 49 101 7 8 14 19 41 4 4 6 8 18
Recove r y
(%)
– 112.2 101.0 91.1 98.4 – 105.6 96.0 92.7 96.3 – 104.0 89.6 107.4 100.7
PS polystyrene, STD standard deviation
aCertified mean particle size, 4.9±0.4 μm; standard deviation, 0.5 μm
bCertified mean particle size, 9.8±0.5 μm; standard deviation, 1.0 μm
cCertified mean particle size, 15.8±0.6 μm; standard deviation, 1.3 μm
Table II. Comparison of Sizing Results for PS Microspheres at Each Threshold Value
Item
Threshold value
Mean Mean+0.5σ Mean+1.0σ Mean+1.5σ
Pre Post Pre Post Pre Post Pre Post
5-μm PS microspheres
Mean (μm) 7.14 6.89 6.30 6.20 5.96 5.18 5.63 4.63
STD (μm) 0.69 5.90 0.58 4.05 0.57 3.42 0.51 2.79
Area (%) 4.44 23.05 3.46 14.51 3.09 10.81 2.76 7.81
Particle number 11 107 11 101 11 106 11 102
Recovery (%) – 96.5 – 98.4 – 86.9 – 82.2
10-μm PS microspheres
Mean (μm) 11.26 11.11 10.58 10.19 10.15 8.50 9.87 7.39
STD (μm) 0.56 7.14 0.65 5.59 0.61 4.87 0.47 4.12
Area (%) 6.98 19.57 6.18 14.48 5.68 11.53 5.37 8.79
Particle number 7 43 7 41 7 46 7 47
Recovery (%) – 98.7 – 96.3 – 83.7 – 74.9
15-μm PS microspheres
Mean (μm) 16.51 17.42 15.79 15.90 15.41 12.56 14.99 9.26
STD (μm) 0.26 8.27 0.36 6.80 0.31 7.07 0.32 6.54
Area (%) 8.57 17.33 7.84 13.98 7.46 11.29 7.06 9.32
Particle number 4 18 4 18 4 21 4 28
Recovery (%) – 105.5 – 100.7 – 81.5 – 61.8
PS polystyrene, STD standard deviation
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yellow parts of PS microspheres in Fig. 5b, while Fig. 7d shows
extraction of only the red part. Figure 7b, c show an interme-
diate degree of polystyrene particle agglomeration and segre-
gation between Fig. 7a, d, respectively. Considering the shape
of polystyrene particles, the binarization threshold value ef-
fectively controlled the 3D region of particles in the Raman
chemical image. In addition, considering the fact that PS mi-
crospheres retained their individual shape and size during the
formulation process, the threshold value determines the par-
ticle agglomeration and segregation in the binary image.
While all binary images are in their true form at each thresh-
old value, the binary threshold values for which an appropri-
ate particle size assessment is possible are discussed below.
Because the absolute value of the peak intensity varies under
various conditions, it is not appropriate to define the general
absolute value as the threshold value; thus, the use of statistics
(e.g., means, standard deviations) is useful.
Binarization Threshold Value Determination
At the binarization threshold value of the mean+0.5σ,
the accuracy of the mean particle sizes in the tablets was good,
and was independent of the particle size and area covered by
PS microspheres. This suggests that the binarization threshold
value and the area measured in the tablets (100×100 μm×3
points) containing the micrometer-scale particles is valid for
this formulation. Binary images of both particle agglomera-
tions and colocalizations were incomplete images of individual
PS microspheres, which is the limitation of image analysis with
only a single binarization threshold for particle sizing. Never-
theless, a statistically reliable number of particles, which in-
cluded complete individual particles, particle agglomerates,
and colocalized particles in the binary images, gave a reliable
mean particle size with a specific binarization threshold value.
Fig. 9. Correlations between mean PS microsphere particle size, preformulation, and
postformulation. Threshold values of a mean, b mean+0.5σ, c mean+1.0σ, and d mean+1.5σ. Blue
circles indicate each result in three different areas of each tablet cross-section
Fig. 10. Binary image of ebastine prior to formulation
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The standard deviation primarily represented the degree of
particle agglomeration and segregation in the tablets.
Validation for Binarization Threshold Value
A higher threshold value identified only parts of the PS
microspheres and resulted in a mean particle size smaller than
the actual size. This trend was more pronounced with larger PS
microspheres prior to formulation. The threshold value of the
mean produced a mean particle size larger than the actual size.
The mean particle size calculated for the PS microspheres
in the tablets reflected the size prior to formulation at the
binarization threshold value of the mean+0.5σ, and good
linearity and accuracy were obtained for the binarization
threshold value (Fig. 9). The threshold may also work beyond
the range of 5–15 μm particle size because there is no clear
trend in the particle size recovery within this size range, and
the threshold may be suitable even for particle size distribu-
tions. Thus, the binarization threshold value of the mean+
0.5σ created binary images that could be used to accurately
estimate the mean particle size of the PS microspheres used in
this formulation.
Application of Binarization Threshold Value to Ebastel Tablet
There are strong reasons for applying this threshold value
of the mean+0.5σ to the Ebastel tablet: the Raman peak of
ebastine at 1,601 cm−1 achieved similar intensity to that of PS
microspheres at 1,605 cm−1 at unit exposure time, as shown in
Fig. 1; the identical qualitative and quantitative excipient
composition in model tablets; and the intensity histogram of
an Ebastel tablet showed a similar pattern to that of
polystyrene microspheres in model tablets, with the
maximum intensity prior to formulation being retained.
However, the binarization threshold value of the mean+0.5σ
is not a general value, and may not be suitable for other APIs.
Applying the binary threshold value of the mean+0.5σ to
the Ebastel tablet provided the mean particle sizes of ebastine
in the Ebastel tablet with good accuracy. The results suggest
that ebastine particles retained their size during the formula-
tion process.
In the histogram of ebastine, it was difficult to clearly
distinguish ebastine from the excipients in a certain domain.
However, the binarization threshold value of the mean+0.5σ
effectively acquired the 3D region of the particles required
from the unresolved distribution, and was validated in the
model tablets. Some pixels with an intensity below the thresh-
old value may have included ebastine particles of less than
1 μm in size mixed with excipients. These particles were below
the quantification limit of the Raman analysis in this study, as
is often the case with conventional particle sizing methods.
The concept of using model tablets for image analysis is
based on the interpretation of the intensity histograms and the
pixel picking method with thresholds. It may not be possible to
simply apply this approach to the particular formulations that
show completely different histogram patterns from that of








Mean (μm) 4.11 4.11 4.71
STD (μm) 3.78 2.92 3.89
Particle number 52 10000 7725
STD standard deviation
Fig. 11. Binarization of Ebastel tablet cross-section. a Intensity histo-
gram at 1,601 cm−1 after preprocessing. Red and blue dashed lines
indicate the maximum and threshold intensity, respectively. b Raman
chemical image of Ebastel tablet cross-section at 1,601 cm−1 after
preprocessing. c Binary image of ebastine
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model tablets; e.g., API particles are well dispersed into the
formulations and the histogram indicates no API-specific dis-
tribution, and all pixels are a mixture of components with the
API maximum intensity prior to formulation not being
retained (only the fact that particle size is affected by formu-
lation process can be determined).
CONCLUSIONS
In this study, we demonstrated that model tablets con-
taining PS microspheres can be used to determine an appro-
priate binarization threshold value for assessing mean particle
size of micrometer-scale components in tablets by using Ra-
man CI. The appropriate value enabled evaluation of the
influence of the formulation process on API particle size.
The model tablets took advantage of the unique physicochem-
ical properties of PS microspheres for Raman particle sizing in
tablets, including the Raman spectrum, particle size, and par-
ticle shape, which remained unchanged throughout the
Ebastel formulation process. The concept of model tablets
containing PS microspheres as particle size standards holds
promise for application to various types of formulation in the
pharmaceutical industry.
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